Elevate Ventures nurtures and develops emerging and existing high-potential businesses into high-performing, Indiana-based companies. They accomplish this by providing rigorous business analysis and robust advisory serivces that connect companies with the resources they need to succeed long-term. As a not-for-profit organization, they are able to offer unbiased, in-depth perspective and recommendations. Emerging, high-potential businesses Elevate Ventures seeks out business endeavors that identify a need in the marketplace and are well-positioned to successfully transition from research to product development to market. High-performing, Indiana-based Companies These companies grow local economies and employment throughout Indiana, in addition to attracting and retaining top-level talent for the Hoosier state. Rigorous business analysis Comprehensive due diligence is critical to determining the long-term financial viability of these companies. Robust advisory services Elevate Ventures provides more than just capital, they partner with entrepreneurs, investors and other local and state organizations to ensure the best return on investment. Resources to succeed long-term In addition to financial resources, Elevate addressees other market barriers, which may include management, business development, talent identification and retention, and specific technology development challenges. They don't just write a check and walk away - they help sustain business success and growth over time. Unbiased, in-depth perspective and recommendations With a seasoned staff and a host of proven outside partners, they provide objectivity and insights that are among the best in their profession.
Eli Lilly and Company, founded in 1876, is an American pharmaceutical company engaged in the discovery, development, manufacture, and sale of a wide range of pharmaceutical products. The company operates facilities in the United States, Puerto Rico, and 25 other countries, distributing its products to approximately 135 countries worldwide. Eli Lilly's product portfolio includes treatments in various therapeutic areas, notably neurosciences and endocrinology. Key products include Zyprexa for schizophrenia and bipolar disorder, Cymbalta for depression and pain management, and several diabetes medications such as Humalog and Byetta. Additionally, the company has a foundation that focuses on improving patient outcomes and enhancing quality of life, alongside supporting educational initiatives in underserved communities, particularly in Indianapolis. Through its research and philanthropic efforts, Eli Lilly aims to address both health and educational challenges.
IU Ventures is dedicated to investing in and supporting early-stage startup companies affiliated with Indiana University. Through initiatives like the IU Angel Network, it connects these startups with prospective investors from the university's extensive global community, which includes alumni, faculty, staff, and students. This network aims to foster an entrepreneurial culture that aligns with Indiana University's mission, ultimately contributing to the economic prosperity of Indiana and beyond. By facilitating these connections, IU Ventures plays a pivotal role in nurturing innovation and entrepreneurship within the university ecosystem.
High Alpha, based in Indianapolis, Indiana, is a venture studio that specializes in creating and scaling early-stage B2B SaaS companies. Founded in 2015, it combines studio services such as design, finance, talent acquisition, marketing, and brand development to support the launch and growth of innovative technology firms. High Alpha Capital, the investment arm of the organization, focuses on funding both its studio companies and emerging B2B SaaS businesses. This integrated approach represents a novel model for entrepreneurship, aiming to streamline processes, enhance growth potential, and facilitate the achievement of significant market presence for its portfolio companies.
Serra Ventures is an early-stage venture capital firm based in Illinois, established in 1998. The firm specializes in investing in technology companies located in emerging technology centers in the Midwest and select areas on the West Coast. Serra Ventures focuses on various sectors, including information technology, devices and instrumentation, and agricultural technologies. By targeting these specific industries, the firm aims to support innovative startups that have the potential for significant growth and impact.
Kinnevik is an industry-focused investment company based in Sweden, with a history dating back to 1936. The company specializes in building digital consumer businesses by partnering with talented founders and management teams in developed and emerging markets. Kinnevik aims to create shareholder and social value by leading fast-growing, well-governed companies that positively impact society. With a focus on disruptive, technology-enabled consumer services, Kinnevik invests globally across various sectors including e-commerce, healthcare, and financial services. The company takes an active role on the boards of its subsidiaries and associated companies, acting as a long-term lead shareholder in large listed entities. Kinnevik's shares are listed on the Nasdaq Stockholm's list for large cap companies.
Founded in 2015, New Stack Ventures is an early-stage venture firm based Chicago, Illinois. The firm targets pre-seed and seed stage startups; investing $400k - $700k from a fund and the largest AngelList syndicate in the Midwest -- including 1000+ angels and family offices.
Oak HC/FT is a Connecticut-based private equity and venture capital firm founded in 2014, specializing in healthcare information and services as well as financial services technology. The firm focuses on driving transformation in these industries by providing strategic counsel, board-level participation, and access to an extensive network of industry leaders. Oak HC/FT has a track record of delivering returns for investors, with numerous successful realizations and companies achieving valuations exceeding $1 billion. The firm invests in startups, early to growth stage companies, and growth-equity opportunities in the United States and Europe, with a particular focus on next-generation payments, data-driven solutions, and services within financial technology. Oak HC/FT typically invests between $5 million and $50 million in growth-stage companies and between $15 million and $35 million in earlier-stage venture startups, taking either minority or majority positions and seeking board participation to support the development of innovative businesses in the healthcare and fintech sectors.
KPS Capital Partners is a private equity firm based in New York, specializing in investments in special situations, including turnarounds, restructurings, bankruptcies, and corporate carve-outs. The firm manages KPS Special Situations Funds, focusing on acquiring controlling equity stakes in underperforming or distressed businesses, particularly those facing closure or significant operational challenges. KPS Capital targets middle-market companies across diverse manufacturing sectors, such as automotive, metals, and consumer products, and emphasizes value creation through both organic growth and strategic acquisitions. The firm typically invests between $100 million and $500 million per transaction, with a preference for companies generating revenues of at least $250 million. KPS Capital seeks to exert control over its investments, often taking board seats, and provides various forms of financing, including exit financing and Debtor-In-Possession funding. Founded in 1991, KPS Capital also maintains an office in Frankfurt, Germany, and primarily focuses its investments in the United States, Canada, and Western Europe.
Town Hall Ventures, founded in 2018 and headquartered in New York, is an investment firm focused on series A and series B investments in healthcare companies across the United States. Specializing in growth capital investments, Town Hall Ventures seeks to support visionary entrepreneurs aiming to revolutionize care delivery and health outcomes for underserved populations covered by Medicare and Medicaid. With a commitment to transforming the U.S. healthcare market through technology, the firm invests in companies at various stages, ranging from early ideas to growth stages, with investments typically ranging from $500,000 to $5,000,000. Town Hall Ventures collaborates with bold entrepreneurs looking to effect systemic change and improve the lives of millions across the country.